These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16099721)

  • 1. Pacific collaboration to eliminate lymphatic filariasis.
    Ichimori K; Crump A
    Trends Parasitol; 2005 Oct; 21(10):441-4. PubMed ID: 16099721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic filariasis elimination in the Pacific: PacELF replicating Japanese success.
    Ichimori K; Graves PM; Crump A
    Trends Parasitol; 2007 Jan; 23(1):36-40. PubMed ID: 17126604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pacific nations lead the way in fighting lymphatic filariasis. Region aims to eliminate.
    Dean M
    Lancet; 2003 Dec; 362(9399):1906. PubMed ID: 14672081
    [No Abstract]   [Full Text] [Related]  

  • 4. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2010 Sep; 85(38):365-72. PubMed ID: 20853547
    [No Abstract]   [Full Text] [Related]  

  • 7. Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998-2017.
    Graves PM; Joseph H; Coutts SP; Mayfield HJ; Maiava F; Ah Leong-Lui TA; Tupuimatagi Toelupe P; Toeaso Iosia V; Loau S; Pemita P; Naseri T; Thomsen R; Berg Soto A; Burkot TR; Wood P; Melrose W; Aratchige P; Capuano C; Kim SH; Ozaki M; Yajima A; Lammie PJ; Ottesen E; Hansell L; Baghirov R; Lau CL; Ichimori K
    Adv Parasitol; 2021; 114():27-73. PubMed ID: 34696844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global programme to eliminate lymphatic filariasis: progress report, 2011.
    Wkly Epidemiol Rec; 2012 Sep; 87(37):346-56. PubMed ID: 22977953
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic tools for filariasis elimination programs.
    Weil GJ; Ramzy RM
    Trends Parasitol; 2007 Feb; 23(2):78-82. PubMed ID: 17174604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010.
    Wkly Epidemiol Rec; 2011 Aug; 86(35):377-88. PubMed ID: 21887884
    [No Abstract]   [Full Text] [Related]  

  • 11. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2009 Oct; 84(42):437-44. PubMed ID: 19860021
    [No Abstract]   [Full Text] [Related]  

  • 12. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2007 Oct; 82(42):361-80. PubMed ID: 17948605
    [No Abstract]   [Full Text] [Related]  

  • 13. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
    Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
    Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A success story: Togo is moving toward becoming the first sub-Saharan African nation to eliminate lymphatic filariasis through mass drug administration and countrywide morbidity alleviation.
    Sodahlon YK; Dorkenoo AM; Morgah K; Nabiliou K; Agbo K; Miller R; Datagni M; Seim A; Mathieu E
    PLoS Negl Trop Dis; 2013; 7(4):e2080. PubMed ID: 23593512
    [No Abstract]   [Full Text] [Related]  

  • 15. Global programme to eliminate lymphatic filariasis: progress report for 2012.
    Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461
    [No Abstract]   [Full Text] [Related]  

  • 16. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions.
    Michael E; Malecela-Lazaro MN; Kabali C; Snow LC; Kazura JW
    Trends Parasitol; 2006 May; 22(5):226-33. PubMed ID: 16564745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Launching a lymphatic filariasis campaign in the Pacific Islands.
    Dean M
    Lancet; 2000 Jul; 356(9224):143. PubMed ID: 10963257
    [No Abstract]   [Full Text] [Related]  

  • 18. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.
    Devi RR; Raju V
    J Vector Borne Dis; 2018; 55(1):20-25. PubMed ID: 29916444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PacELF programme: will mass drug administration be enough?
    Burkot T; Ichimori K
    Trends Parasitol; 2002 Mar; 18(3):109-15. PubMed ID: 11854087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and future prospects of the Global Lymphatic Filariasis Programme.
    Molyneux DH; Taylor MJ
    Curr Opin Infect Dis; 2001 Apr; 14(2):155-9. PubMed ID: 11979126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.